Antibiotic resistance is a global health issue published by the World Health Organization (WHO).

Multi-drug-resistant Gram-negative bacteria has increased worldwide and have become a serious problem in recent medical-related infections. In particular, the World Health Organization has designated Carbapenem-resistant Pseudomonas aeruginosa as one of the top priority pathogens for new antibiotic research and development.

There is an alternative. In Korea, 'Zerbaxa (Ceftolozane/Tazobactam)' has been introduced, and other next-generation antibiotics are also being prepared for approval by the MFDS.

The problem is insurance benefits. This is because antibiotic drugs are not easy